“what is gluten?”的搜索结果，显示 131-140 项，共有 7786 项

1. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   The primary aim of this study is to define a comprehensive digital phenotype that predicts risk for near-future relapse or relapse in alcohol use in ...

2. HDL 胆固醇：如何增加“有益”胆固醇 - 妙佑医疗国际

   What is cholesterol? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hbc. Accessed Oct. 5, 2018.

3. 癫痫 - 症状与病因- 妙佑医疗国际

   了解这种导致癫痫发作的疾病。了解哪些症状与不同类型的癫痫发作有关，以及如何治疗。

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is threefold: the first aim is to use patient-derived fresh tumor tissue to create cell lines and 3D tumor models ( ...

5. 1 型糖尿病- 症状与病因- 妙佑医疗国际

   Summary of revisions: Standards of medical care in diabetes — 2022. Diabetes Care. 2022; doi:10.2337/dc22-Srev. ... What is diabetes? ... Diabetes mellitus (DM).

6. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. This study aims to compare the fatty acid composition of small sample of fat (visceral and subcutaneous) removed at the time of ...

7. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) treatment. Exclusion ...

8. 普通内科- 临床试验- 妙佑医疗国际

   探索针对健康生活方式、早期疾病检测、预防策略和成人不明原因症状诊断的服务。

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is: To assess the efficacy of treatment with checkpoint inhibitors (Pembrolizumab or Nivolumab) in metastatic gastric ...

10. 内分泌科- 临床试验- 妙佑医疗国际

    Rochester, Minn. Muscle insulin resistance is a hallmark of upper body obesity (UBO) and Type 2 diabetes (T2DM). It is unknown whether muscle free fatty acid ( ...